Cargando…

Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications

Electrospun fibers have emerged as a relatively new delivery platform to improve active agent retention and delivery for intravaginal applications. While uniaxial fibers have been explored in a variety of applications including intravaginal delivery, the consideration of more advanced fiber architec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tyo, Kevin M., Minooei, Farnaz, Curry, Keegan C., NeCamp, Sarah M., Graves, Danielle L., Fried, Joel R., Steinbach-Rankins, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523330/
https://www.ncbi.nlm.nih.gov/pubmed/30987206
http://dx.doi.org/10.3390/pharmaceutics11040160
_version_ 1783419309386629120
author Tyo, Kevin M.
Minooei, Farnaz
Curry, Keegan C.
NeCamp, Sarah M.
Graves, Danielle L.
Fried, Joel R.
Steinbach-Rankins, Jill M.
author_facet Tyo, Kevin M.
Minooei, Farnaz
Curry, Keegan C.
NeCamp, Sarah M.
Graves, Danielle L.
Fried, Joel R.
Steinbach-Rankins, Jill M.
author_sort Tyo, Kevin M.
collection PubMed
description Electrospun fibers have emerged as a relatively new delivery platform to improve active agent retention and delivery for intravaginal applications. While uniaxial fibers have been explored in a variety of applications including intravaginal delivery, the consideration of more advanced fiber architectures may offer new options to improve delivery to the female reproductive tract. In this review, we summarize the advancements of electrospun coaxial, multilayered, and nanoparticle-fiber architectures utilized in other applications and discuss how different material combinations within these architectures provide varied durations of release, here categorized as either transient (within 24 h), short-term (24 h to one week), or sustained (beyond one week). We seek to systematically relate material type and fiber architecture to active agent release kinetics. Last, we explore how lessons derived from these architectures may be applied to address the needs of future intravaginal delivery platforms for a given prophylactic or therapeutic application. The overall goal of this review is to provide a summary of different fiber architectures that have been useful for active agent delivery and to provide guidelines for the development of new formulations that exhibit release kinetics relevant to the time frames and the diversity of active agents needed in next-generation multipurpose applications.
format Online
Article
Text
id pubmed-6523330
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-65233302019-06-04 Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications Tyo, Kevin M. Minooei, Farnaz Curry, Keegan C. NeCamp, Sarah M. Graves, Danielle L. Fried, Joel R. Steinbach-Rankins, Jill M. Pharmaceutics Review Electrospun fibers have emerged as a relatively new delivery platform to improve active agent retention and delivery for intravaginal applications. While uniaxial fibers have been explored in a variety of applications including intravaginal delivery, the consideration of more advanced fiber architectures may offer new options to improve delivery to the female reproductive tract. In this review, we summarize the advancements of electrospun coaxial, multilayered, and nanoparticle-fiber architectures utilized in other applications and discuss how different material combinations within these architectures provide varied durations of release, here categorized as either transient (within 24 h), short-term (24 h to one week), or sustained (beyond one week). We seek to systematically relate material type and fiber architecture to active agent release kinetics. Last, we explore how lessons derived from these architectures may be applied to address the needs of future intravaginal delivery platforms for a given prophylactic or therapeutic application. The overall goal of this review is to provide a summary of different fiber architectures that have been useful for active agent delivery and to provide guidelines for the development of new formulations that exhibit release kinetics relevant to the time frames and the diversity of active agents needed in next-generation multipurpose applications. MDPI 2019-04-03 /pmc/articles/PMC6523330/ /pubmed/30987206 http://dx.doi.org/10.3390/pharmaceutics11040160 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tyo, Kevin M.
Minooei, Farnaz
Curry, Keegan C.
NeCamp, Sarah M.
Graves, Danielle L.
Fried, Joel R.
Steinbach-Rankins, Jill M.
Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications
title Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications
title_full Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications
title_fullStr Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications
title_full_unstemmed Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications
title_short Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications
title_sort relating advanced electrospun fiber architectures to the temporal release of active agents to meet the needs of next-generation intravaginal delivery applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523330/
https://www.ncbi.nlm.nih.gov/pubmed/30987206
http://dx.doi.org/10.3390/pharmaceutics11040160
work_keys_str_mv AT tyokevinm relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications
AT minooeifarnaz relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications
AT currykeeganc relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications
AT necampsarahm relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications
AT gravesdaniellel relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications
AT friedjoelr relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications
AT steinbachrankinsjillm relatingadvancedelectrospunfiberarchitecturestothetemporalreleaseofactiveagentstomeettheneedsofnextgenerationintravaginaldeliveryapplications